Pharm-to-Trial expansion RxE2 is launching a Pharm-to-Trial model utilizing local community pharmacies as regional hubs, signaling a scalable channel to accelerate patient recruitment and site reach for clinical trials.

Community pharmacist network Leverage a vast, trusted network of community pharmacists to address recruitment, engagement, and retention challenges, presenting a differentiated value proposition to pharma clients seeking diverse patient enrollment.

AI driven efficiency The use of AI and machine learning across trial design, patient matching, and logistics offers a compelling efficiency and cost-reduction story to pharmaceutical teams aiming to shorten trial timelines.

Strategic partnerships Recent integrations and collaborations, such as Hawthorne Health, indicate momentum in building an integrated network of trial locations, opening opportunities for co-sell with mid-market health tech and services firms.

Financial and awards signal viability Healthy revenue range with notable recognition as a best tech startup in North Dakota enhances credibility for enterprise pharma buyers seeking innovative, scalable technology partners.